Mitochondrial complex I inhibition enhances astrocyte responsiveness to pro-inflammatory stimuli
Inhibition of the mitochondrial oxidative phosphorylation (OXPHOS) system can lead to metabolic disorders and neurodegenerative diseases. In primary mitochondrial disorders, reactive astrocytes often accompany neuronal degeneration and may contribute to neurotoxic inflammatory cascades that elicit brain lesions. The influence of mitochondria to astrocyte reactivity as well as the underlying molecular mechanisms remain elusive. Here we report that mitochondrial Complex I dysfunction promotes neural progenitor cell differentiation into astrocytes that are more responsive to neuroinflammatory stimuli. We show that the SWItch/Sucrose Non-Fermentable (SWI/SNF/BAF) chromatin remodeling complex takes part in the epigenetic regulation of astrocyte responsiveness, since its pharmacological inhibition abrogates the expression of inflammatory genes. Furthermore, we demonstrate that Complex I deficient human iPSC-derived astrocytes negatively influence neuronal physiology upon cytokine stimulation. Together, our data describe the SWI/SNF/BAF complex as a sensor of altered mitochondrial OXPHOS and a downstream epigenetic regulator of astrocyte-mediated neuroinflammation.
Authors
- Lena Wischhof (ORCID: https://orcid.org/0000-0002-2203-408X)
- Marc Beyer (ORCID: https://orcid.org/0000-0001-9704-148X)
- Daniele Bano (ORCID: https://orcid.org/0000-0002-9617-5504)
- Dan Ehninger (ORCID: https://orcid.org/0000-0001-7464-1335)
- Lorenzo Bonaguro (ORCID: https://orcid.org/0000-0001-9675-7208)
- Pierluigi Nicotera (ORCID: https://orcid.org/0000-0003-1175-7466)
- Amal John Mathew
Institutions
- University of Bonn (DE)
- German Center for Neurodegenerative Diseases (DE)
- Epigenomics (Germany) (DE)
Publication Details
- Journal
- Scientific Reports
- Published
- 2024-11-08
- DOI
- https://doi.org/10.1038/s41598-024-78434-y
- Citations
- 1
- Primary Topic
- Neuroinflammation and Neurodegeneration Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.25
Funders
- European Commission
- Deutsche Forschungsgemeinschaft
- Deutsches Zentrum für Neurodegenerative Erkrankungen
- HORIZON EUROPE Framework Programme
- H2020 Marie Skłodowska-Curie Actions